Clinical Trials of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma

by Anne Dyhl-Polk, Marta Kramer Mikkelsen, Morten Ladekarl, Dorte Lisbet Nielsen
Published 2021-06-01

Wnt5a expression and prognosis in stage II–III colon cancer

by Cecilia Margareta Lund, Anne Dyhl-Polk, Dorte Lisbeth Nielsen, Lene Buhl Riis
Published 2021-01-01

Inhibitors targeting CDK4/6, PARP and PI3K in breast cancer: a review

by Siti Muhamad Nur Husna, Hern-Tze Tina Tan, Rohimah Mohamud, Anne Dyhl-Polk, Kah Keng Wong
Published 2018-11-01